Prediction of<sup>177</sup>Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study-Reference-Cited by-同舟云学术

Prediction of¹⁷⁷Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study

Published:2023-12-21 Issue:2 Volume:65 Page:236-244
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Mileva Magdalena,Marin Gwennaëlle,Levillain Hugo,Artigas Carlos,Van Bogaert Camille,Marin Clémentine,Danieli Rachele,Deleporte Amelie,Picchia Simona,Stathopoulos Konstantinos,Jungels Christiane,Vanderlinden Bruno,Paesmans Marianne,Ameye Lieveke,Critchi Gabriela,Taraji-Schiltz Loubna,Velghe Chloe,Wimana Zéna,Bali Maria,Hendlisz Alain,Flamen Patrick,Karfis Ioannis

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference33 articles.

1. Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?;Das;Curr Oncol Rep.,2021

2. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

3. Somatostatin receptors in the diagnosis and therapy of neuroendocrine tumor;Wängberg;Oncologist.,1997

4. Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas

5. Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative SPECT/CT Metrics in Early Prediction of [¹⁷⁷Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients;Journal of Nuclear Medicine;2024-09-12

2. The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-05

3. The Translation of Dosimetry into Clinical Practice: What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice;Journal of Nuclear Medicine;2024-09-05

4. Patient-Specific Dosimetry Evaluations in Theranostics Software for Internal Radiotherapy;Applied Sciences;2024-08-20

5. Retrospective evaluation of the predictive value of tumour burden at baseline [68 Ga]Ga-DOTA-TOC or -TATE PET/CT and tumour dosimetry in GEP-NET patients treated with PRRT;EJNMMI Reports;2024-08-08